Standing for 25% of Each Day May Reduce Obesity Risk

Share this content:
Standing for 25% of Each Day May Reduce Obesity Risk
Standing for 25% of Each Day May Reduce Obesity Risk

Standing for at least 25% of each day may reduce the risk of obesity, a new study conducted by the American Cancer Society and The Cooper Institute and published in the journal Mayo Clinic Proceedings has shown.1

According to the American Cancer Society, being overweight or obese is clearly associated with an increased risk of many cancers, including breast in postmenopausal women, colorectal, endometrial, esophageal, kidney, and pancreatic cancers. Being overweight or obese may also elevate the risk for gallbladder, liver, cervical, and ovarian cancers; aggressive forms of prostate cancer; multiple myeloma; and non-Hodgkin lymphoma.2

For the study, researchers evaluated reported standing habits in relation to objectively measured obesity and metabolic risk among more than 7000 adult patients receiving preventive medicine care at Cooper Clinic in Texas.

Results showed that among men, standing for a quarter of the day was linked to a 32% reduction in the likelihood of obesity, while standing half the day was linked with a 59% reduced likelihood of obesity. Among women, standing one-quarter, half, and three-quarters of the day was associated with a 35%, 47%, and 57% reduced likelihood of obesity, respectively.

Researchers also found that 150 minutes of moderate exercise and/or 75 minutes of vigorous activity per day in combination with standing further reduced the risk for obesity.

The authors note that additional prospective studies are necessary to determine whether standing has protective health benefits, and acknowledge that standing is also associated with adverse health effects, such as an increased risk for varicose veins.


1. Standing and exercise linked to lower odds of obesity. EurekAlert! website. November 3, 2015. Accessed November 3, 2015.

2. Does body weight affect cancer risk? American Cancer Society website. April 24, 2015. Accessed November 3, 2015.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs